15 results
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... Luminal A-like (ER ... Early #Breast #Cancer ... Management #Algorithm #treatment ... #oncology
Treatment of breast cancer: a simplified view
surgical therapy - 5-7 weeks
 - lumpectomy +
 - radiation
Treatment of breast ... cancer: a simplified ... 10 years - if ER ... #treatment #management ... timeline #simplified #oncology
Breast Cancer Subtypes 
Histological Subtypes:
 • Preinvasive: Ductal carcinoma in situ (DCIS). Lobular carcinoma in situ
Breast Cancer Subtypes ... Triple-negative (ER ... 0111-2 #Breast #Cancer ... #Subtypes #oncology ... #classification
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... of cancer-associated ... #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE in cancer ... thrombosis in cancer ... #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
Approach to the Rash in a an oncology patient - MINT-C Mnemonic
M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Gangrenosum, NEH T - Treatment ... #skin #Rash #oncology ... differential #diagnosis #cancer ... MINTC #Mnemonic #dermatology
Acute Kidney Injury (AKI) in Patients with Cancer 

Cancer Related 
• Hypercalcemia 
• Intravenous contrast 
•
Patients with Cancer ... Cancer Related ... malignancies Treatment ... #Oncology #Differential ... #Diagnosis #Classification
Symptoms Distinguishing Groups of Cutaneous Drug Reactions
IgE-mediated reactions:
 • Onset minutes to hours into treatment course
to hours into treatment ... Onset days into treatment ... Drug #Reactions #dermatology ... #clinical #comparison ... #classification
Hodgkin's Lymphoma vs Non-Hodgkin's Lymphoma - Comparison

Hodgkin's Lymphoma:
 • Epidemiology: young adults 20-30, older 50-70
 •
Non-Hodgkin's Lymphoma - Comparison ... translocation • Types: Classification ... #NonHodgkins #comparison ... #oncology #diagnosis ... #differential #hematology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions